Daron Evans
CIK 1411726 · CFO · last filed 2026-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.57M
Companies
4
Total Filings
71
Lifetime Open-Market Net
$739.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RZLT | CFO | 418,400 | $4.69 | $1.96M | $664.7K | 19 | 2026-07-07 |
| NEPH | CEO Specialty Renal Products | 143,162 | $4.21 | $602.7K | $59.9K | 8 | 2021-06-01 |
| CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Chief Financial Officer | 13,352 | — | — | $0 | 4 | 2011-04-19 |
| CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted | Chief Financial Officer | 67 | $13.96 | $935 | $14.7K | 9 | 2010-02-17 |
Recent Filings · Page 3 of 8
71 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-25 | NEPH | Exer (X) | +2,222 | $6.0K | EDGAR |
| 2020-03-12 | NEPH | Buy (P) | +2,500 | $16.6K | EDGAR |
| 2020-03-05 | NEPH | Buy (P) | +2,500 | $21.1K | EDGAR |
| 2020-02-05 | NEPH | Grant (A) | — | $0 | EDGAR |
| 2019-12-18 | NEPH | Grant (A) | +9,282 | $0 | EDGAR |
| 2019-11-18 | NEPH | Buy (P) | +1,000 | $8.3K | EDGAR |
| 2019-08-22 | NEPH | Buy (P) | +2,000 | $13.8K | EDGAR |
| 2019-08-13 | — | Grant (A) | — | $0 | |
| 2019-06-14 | — | Buy (P) | +43,172 | $25.8K | |
| 2018-12-18 | — | Grant (A) | +108,296 | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.